ImportantUpdates
Biocon Pharma, a subsidiary, received Health Canada approval for Micafungin for injection (50/100 mg), used for Candidiasis.
Biocon LimitedBIOCON · Filed with the exchange
This approval expands Biocon's generics portfolio, enhancing its market position in biosimilars and generics.
No comments yet. Be the first.